FDA Investigator Arindam Dasgupta, PhD
Arindam Dasgupta, PhD has inspections in 7 countries as of 22 Jun 2023. Arindam Dasgupta, PhD has collaborated with a combined 3564 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
29
Last Inspection Date:
22 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India,
United Kingdom of Great Britain and Northern Ireland,
Germany,
France,
Canada,
Netherlands
Co-Investigator(s):
Ademola O Daramola,
Alanna Lmussawwir Bias,
Allen F Hall,
Amanda E Lewin, PhD,
Amber G Chung,
Ana P Barido,
Angela E Glenn,
Anh M Lac,
Anita R Michael,
Anna M Brannen,
Anthony N Onianwa,
Ashar P Parikh,
Azza Talaat,
Bonita S Chester,
Brandon L Mariner,
Brooke K Higgins,
Bruce H Mccullough,
Byungja E Marciante,
Candice C Mandera,
Candice C Mandero,
Candice J Cortes,
Carl Lee,
Carla J Lundi,
Carol Mrivera Lopez, PhD,
Carol Rivera Lopez, PhD,
CDR Rochelle B Young, RPh, MSA,
Charles A Snipes, PhD,
Charles R Bonapace, PhD,
Claire M Minden,
Comyar Shoghi,
Courtney N Long,
Craig A Garmendia,
Cynthia A Harris, MD, RN,
Cynthia White,
Daniel J Roberts,
Daniel L Aisen,
David K Glasgow,
David L Chon,
David R Heiar,
Dawn C Olenjack,
Dawn L Wydner,
Denise M Visco, Investigator,
Diane Cvan Leeuwen,
Dianne H Milazzo,
Dipesh K Shah,
Douglas Florentino,
Dr. Abhijit Raha, PhD,
Dr. Gopa Biswas, PhD,
Dr. Sriram Subramaniam, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dustin R Abaonza,
Elise A Murphy,
Erin M Mcdowell,
Farhana Khan,
Gajendiran Mahadevan, PhD,
Gene R Gunn,
Geoffrey K Kilili,
George C Amedro,
George J Flynn,
Gerald Mierle,
Geraldine D Sanders,
Gifford Whitehurst, Jr,
Gopa Bisivas,
Gulshan R Anand,
Hasan A Irier, PhD,
Hector J Colon Torres,
Huixia Zhang,
Ivis Lnegron Torres,
Jackie O'shaughnessy,
Jacqueline A O'shanghnessy, PhD,
Jacqueline A O'shaughnessy, PhD,
Jacqueline A Shaughnessy, PhD,
Jacqueline N O'shaughnessy,
Jane M Kreis,
Janete F Guardia,
Jaqueline A O'shaughnessy,
Jean M Kelahan,
Jeanne J Thai,
Jeffrey M Watson,
Jennifer Adams, MPH,
Jennifer C Adams,
Jennifer L Degroot,
Jennifer L Johnson,
Jennifer L Sheehan,
John A Iwen,
John A Kadavil, PhD,
Jonee J Mearns,
Joseph L Despins, PhD,
Jyoti B Patel, PhD,
Kara A Scheibner, PhD,
Karen M Cooper,
Katherine Szestypalow,
Kent A Conforti,
Kevin P Foley,
Kim Lthomas Cruse,
Kristin M Abaonza,
Lakisha M Williams,
Lance M De Souza, MBA,
LCDR Jennifer H Rhyu,
Lequita M Mayhew,
Linda M Cheny,
Linda R Kuchenthal,
Lisa B Orr,
M Patriciaurphy Murphy,
Marcus F Yambot,
Margaret M Sands,
Marie K Kinkade,
Marion W Nadeau,
Martin K Yau, PhD,
Martin K You,
Mary K Kinkade,
Mathew R Manen,
Matthew C Watson,
Matthew R Mcnew,
Melkamu Getie Kebtie, PhD,
Michael F Skelly, PhD,
Michael Serrano,
Mike M Rashti,
Minh D Phan,
Mohsen Rajabi Abhari, FDA,
Mra Mcculloughj,
Myra K Casey,
Nathaniel R Esaw,
Nebil A Oumer,
Nerizza B Dalena,
Nerizza B Guerin,
Nicola M Fenty Stewart,
Nilufer M Tampal, PhD,
Nina Yang,
Niraj R Mehta, PhD,
Patrick D Stone, MS,
Paula J Bretz,
Peter E Baker,
Regina T Brown,
Richard H Penta,
Robert C Steyert,
Robert L Lewis, Jr,
Roger F Zabinski,
Ronda R Loyd Jones,
Ruben C Ayala, PharmD,
Sam H Haidar, PhD,
Samantha J Pinizzotto, D V M,
Samuel H Chan, PharmD,
Sandra A Hughes,
Sandra S Saniga,
Scott B Laufenberg,
Sean Y Kassim, PhD,
Seongeun Cho (Julia), PhD,
Sharon K Thoma, PharmD,
Sharon K Thomas,
Sherry I Seerist,
Sherry L Secrist, BLT DO,
Srinivas R Chennamaneni, PhD,
Sripal R Mada, PhD,
Stacey A Priest,
Stacey S Degarmo,
Stanley Au,
Stephanie L Shapley,
Stephanie Mangigian, MS/OSH, RN,
Stephen D Brown,
Steven P Donald,
Susanne M Richardson, MSc RAC ELS,
Taichun Qin, PhD,
Tamal K Chakraborti, PhD,
Terrance L Thomas,
Thea C Grome,
Thomas W Gordon,
Tiara Nbrown Crosen,
Tiffani D Wilson,
Timothy C Grome,
Torrance J Slayton,
Tracey L Harris,
Uttaniti Limchumroon (Tom),
Vickie J Kanion,
Walden H Lee,
William H Linkroum,
Xiaohan Cai, PhD,
Xikui Chen (nmi), PhD,
Xingfang Li, MD,
Yanming An, PhD,
Yih Chain Huang, PhD,
Young M Choi, PhD,
Young M Yoon,
Yumi J Hiramine,
Yvins Dezan
Arindam Dasgupta, PhD's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more